Sellas Life Sciences Group Inc (SLS) — Cash Flow-to-Debt Ratio
Sellas Life Sciences Group Inc (SLS) has a Cash Flow-to-Debt Ratio of -0.66x as of December 2025, meaning its operating cash flow of $-4.92 Million could theoretically repay -1% of its total liabilities ($7.47 Million) in one year. Check SLS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sellas Life Sciences Group Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Sellas Life Sciences Group Inc across 19 annual periods. Also explore Sellas Life Sciences Group Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Sellas Life Sciences Group Inc (2007–2025)
Year-by-year debt coverage analysis for Sellas Life Sciences Group Inc. For market capitalisation and broader financial context, see how much is Sellas Life Sciences Group Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.80x | $-28.39 Million | $7.47 Million | ▼ -6.9% |
| 2024 | -3.55x | $-35.40 Million | $9.97 Million | ▼ -60.5% |
| 2023 | -2.21x | $-31.41 Million | $14.20 Million | ▼ -49.6% |
| 2022 | -1.48x | $-23.81 Million | $16.09 Million | ▲ +65.4% |
| 2021 | -4.28x | $-26.02 Million | $6.08 Million | ▼ -643.1% |
| 2020 | -0.58x | $-10.42 Million | $18.09 Million | ▲ +65.7% |
| 2019 | -1.68x | $-17.64 Million | $10.52 Million | ▲ +35.6% |
| 2018 | -2.61x | $-30.42 Million | $11.67 Million | ▼ -646.2% |
| 2017 | -0.35x | $-10.99 Million | $31.46 Million | ▲ +71.1% |
| 2016 | -1.21x | $-44.91 Million | $37.15 Million | ▼ -72.3% |
| 2015 | -0.70x | $-48.16 Million | $68.63 Million | ▲ +28.9% |
| 2014 | -0.99x | $-42.87 Million | $43.43 Million | ▼ -180.3% |
| 2013 | -0.35x | $-28.91 Million | $82.09 Million | ▲ +54.3% |
| 2012 | -0.77x | $-20.96 Million | $27.23 Million | ▼ -9.5% |
| 2011 | -0.70x | $-14.67 Million | $20.86 Million | ▲ +65.4% |
| 2010 | -2.03x | $-10.26 Million | $5.05 Million | ▲ +4.8% |
| 2009 | -2.14x | $-11.77 Million | $5.51 Million | ▲ +68.5% |
| 2008 | -6.78x | $-9.43 Million | $1.39 Million | ▼ -48.4% |
| 2007 | -4.57x | $-6.05 Million | $1.32 Million | — |